Health Sciences Acquisitions Corporation 2 (HSAQ): Price and Financial Metrics


Health Sciences Acquisitions Corporation 2 (HSAQ): $10.40

0.01 (+0.10%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

HSAQ Stock Price Chart Interactive Chart >

Price chart for HSAQ

HSAQ Price/Volume Stats

Current price $10.40 52-week high $14.66
Prev. close $10.39 52-week low $9.90
Day low $10.27 Volume 18,000
Day high $10.40 Avg. volume 43,766
50-day MA $10.36 Dividend yield N/A
200-day MA $11.32 Market Cap 212.68M

Health Sciences Acquisitions Corporation 2 (HSAQ) Company Bio


Health Sciences Acquisitions Corporation 2 intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.


HSAQ Latest News Stream


Event/Time News Detail
Loading, please wait...

HSAQ Latest Social Stream


Loading social stream, please wait...

View Full HSAQ Social Stream

Latest HSAQ News From Around the Web

Below are the latest news stories about Health Sciences Acquisitions Corp 2 that investors may wish to consider to help them evaluate HSAQ as an investment opportunity.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation of Class Action Lawsuit and Upcoming Deadline - IMVT; HSACU; HSAC; and HSACW

Pomerantz LLP announces that a class action lawsuit has been filed against Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation ("HSAC", "Immunovant", or the "Company") (NASDAQ: IMVT; HSACU; HSAC; and HSACW) and certain of its officers. The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 21-cv-00918, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Immunovant securities between October 2, 2019 and February 1, 2021, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (t...

Yahoo | March 31, 2021

Read More 'HSAQ' Stories Here

HSAQ Price Returns

1-mo 4.00%
3-mo -3.79%
6-mo -9.72%
1-year N/A
3-year N/A
5-year N/A
YTD -18.81%
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9483 seconds.